MedPath

Clinical significance and molecular mechanism of Wendan Decoction in early intervention of phlegm-dampness metabolic syndrome

Phase 1
Recruiting
Conditions
metabolic syndrome
Registration Number
ITMCTR2200005829
Lead Sponsor
Shunde District Hospital of Chinese Medicine of Foshan City
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) those who meet the diagnostic criteria of metabolic syndrome and belong to TCM phlegm-dampness constitution;
(2) those who have not received any corresponding medication for blood pressure, and/or lipids, and/or blood glucose;
(3) Aged between 18 and 70;
(4) The informed consent is signed.

Exclusion Criteria

(1) secondary blood pressure, and/or lipids, and/or elevated blood sugar or obesity due to other diseases;
(2) patients with excessive blood pressure, and/or blood lipid, and/or blood glucose elevation, or complications, which are not suitable for simple lifestyle intervention and need immediate drug intervention;
(3) those who are taking or have taken traditional Chinese medicine decoction or patent Chinese medicine with similar effect in recent 1 month;
(4) those who are pregnant, breast-feeding or have pregnancy needs;
(5) allergic constitution or allergic history to the taste of Wendan Decoction;

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The rate of metabolic index returning to normal;
Secondary Outcome Measures
NameTimeMethod
chinese medicine therapeutic effect;Adverse drug reactions;
© Copyright 2025. All Rights Reserved by MedPath